$181.50-8.38% · 3M
Moving avg
1W-3.81%
1M-22.96%
3M-8.38%
6M+25.81%
YTD+58.50%
1Y+37.42%
3Y+69.69%
5Y+38.26%
52-week range
$101.0058% of range$239.64
Company health
Value4/6
Growth2/6
Profitability2/6
Health4/6
Dividend0/6
Bull vs bear
Strengths
- Analysts see 32% upside to a $240 target
Risks
No obvious red flags from the metrics.
Key statistics
Valuation
Market cap
$11.65B
Enterprise value
$27.39B
P/E ratio (TTM)
22.87x
P/S ratio (TTM)
1.08x
EV/EBITDA
10.15x
Per share & returns
EPS (TTM)
$11.60
Dividend yield
0.00%
Beta (1Y)
0.88
30-day change
-22.96%
Trading
Volume (24h)
1.70M
Previous close
$178.34
Shares outstanding
64.20M
About DaVita Inc.
Sector
Healthcare
Industry
Medical - Care Facilities
Exchange
NYSE
Symbol
DVA
DaVita Inc. is a large-cap healthcare company in the Medical - Care Facilities industry. Its shares are listed on NYSE (United States) and trade under the ticker DVA.
Frequently asked questions
What is DaVita Inc.'s market cap?
DaVita Inc. (DVA) has a market capitalization of $11.65B.
What is DaVita Inc.'s P/E ratio?
DaVita Inc. trades at a price-to-earnings (P/E) ratio of 22.87.
What exchange does DVA trade on?
DVA trades on NYSE.
Appears in
Eli Lilly and CompanyLLY
$1,220.51+0.45%
$1.15T cap
Johnson & JohnsonJNJ
$260.86+0.41%
$628.65B cap
AbbVie Inc.ABBV
$248.66-0.57%
$439.33B cap
UnitedHealth Group IncorporatedUNH
$405.59+0.85%
$368.33B cap
Roche Holding AGSWX: ROP
CHF 365.50-0.92%
$357.68B cap
Merck & Co., Inc.MRK
$132.93+1.92%
$328.31B cap
Novartis AGSWX: NOVN
CHF 124.20-1.32%
$290.23B cap
AstraZeneca PLCLON: AZN
£117.02-1.20%
$244.93B cap